Safety of Proton Pump Inhibitors in Pediatric Population: A Systematic Review

被引:3
|
作者
Alla, Deekshitha [1 ]
Shah, Dhruv Jayeshkumar [2 ]
Seepana, Muneesh [3 ]
Salian, Rishabh Baskara [4 ]
Alla, Sai Santhosha Mrudula [1 ]
Krishna Mohanan, Midhun [5 ]
Sabiroglu, Mert [6 ]
Vegesna, Mohan Sai Sunith [7 ]
Singh, Aradhya [8 ]
Gupta, Srajan [9 ]
Shivalingappa Rekha, Shushrutha [10 ]
机构
[1] Andhra Med Coll, Visakhapatnam, Andhra Pradesh, India
[2] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[3] Guntur Med Coll, Guntur, Andhra Pradesh, India
[4] Kasturba Med Coll & Hosp, Mangalore, Karnataka, India
[5] Sree Uthradom Thirunal SUT Acad Med Sci, Thiruvananthapuram, Kerala, India
[6] Koc Univ, Sch Med, Istanbul, Turkiye
[7] Jilin Univ, Changchun, Peoples R China
[8] Spartan Hlth Sci Univ, Spartan Dr,LC 12101, Vieux Fort, St Lucia
[9] SVMC, Tirupati, Andhra Pradesh, India
[10] Sri Devaraj Urs Med Coll, Kolar, Karnataka, India
关键词
proton pump inhibitors; pediatric population; GI infections; secondary infections; adverse effects; GASTROESOPHAGEAL-REFLUX DISEASE; LONG-TERM USE; OPEN-LABEL; CHILDREN; PHARMACOKINETICS; EFFICACY; RABEPRAZOLE; RISK; TOLERABILITY; ADOLESCENTS;
D O I
10.1177/2333794X241248967
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. Commonly recommended drugs for adults and children include proton pump inhibitors (PPIs), proven effective for treating peptic diseases like stomach ulcers, GERD, and Helicobacter pylori infections in children over 1-year-old. Yet, prolonged PPI use carries higher risks of adverse reactions, prompting this study's analysis. Methods. We have performed a systematic review of 30 articles, which include a total of 762 505 pediatric patients. Results. Adverse effects were encountered in 6.98% of the population. The 5 most common adverse effects were respiratory tract complications, gastrointestinal complications, urinary tract infections, asthma, and ENT infections. Conclusion. Hence, PPIs should be prescribed only when necessary, and physicians should prioritize patient education when considering their use.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Pharmacogenetics of the proton pump inhibitors: A systematic review
    Chong, E
    Ensom, MHH
    PHARMACOTHERAPY, 2003, 23 (04): : 460 - 471
  • [2] Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review
    Shiraev, Timothy P.
    Bullen, Andrew
    HEART LUNG AND CIRCULATION, 2018, 27 (04): : 443 - 450
  • [3] Proton pump inhibitors and colorectal cancer: A systematic review
    Patel, Agastya
    Spychalski, Piotr
    Antoszewska, Magdalena
    Regula, Jaroslaw
    Kobiela, Jarek
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (44) : 7716 - 7733
  • [4] Proton pump inhibitors and colorectal cancer: A systematic review
    Agastya Patel
    Piotr Spychalski
    Magdalena Antoszewska
    Jaroslaw Regula
    Jarek Kobiela
    World Journal of Gastroenterology, 2021, 27 (44) : 7716 - 7733
  • [5] Strategies for discontinuation of proton pump inhibitors: a systematic review
    Haastrup, Peter
    Paulsen, Maja S.
    Begtrup, Luise M.
    Hansen, Jane M.
    Jarbol, Dorte E.
    FAMILY PRACTICE, 2014, 31 (06) : 625 - 630
  • [6] Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials
    Fernandez-Gonzalez, Sara Maria
    Moreno-Alvarez, Ana
    Solar-Boga, Alfonso
    CHILDREN-BASEL, 2024, 11 (03):
  • [7] Safety of proton pump inhibitors
    Waldum, HL
    Brenna, E
    Martinsen, TC
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (11) : 1537 - 1538
  • [8] Safety of proton pump inhibitors
    Esplugues, Juan V.
    Marti-Cabrera, Miguel
    Ponce, Julio
    MEDICINA CLINICA, 2006, 127 (20): : 790 - 795
  • [9] Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors
    Salvo, Elizabeth M.
    Ferko, Nicole C.
    Cash, Sarah B.
    Gonzalez, Ailish
    Kahrilas, Peter J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (02) : 129 - 143
  • [10] A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
    Dipasquale, Valeria
    Cicala, Giuseppe
    Spina, Edoardo
    Romano, Claudio
    FRONTIERS IN PHARMACOLOGY, 2022, 13